- Home
- FBRX vs CUBA Comparison
FBRX vs CUBA Comparison
Compare FBRX & CUBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- CUBA
- Stock Information
- Founded
- FBRX N/A
- CUBA 1992
- Country
- FBRX United States
- CUBA United States
- Employees
- FBRX N/A
- CUBA N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- CUBA Investment Managers
- Sector
- FBRX Health Care
- CUBA Finance
- Exchange
- FBRX Nasdaq
- CUBA Nasdaq
- Market Cap
- FBRX 35.3M
- CUBA 41.2M
- IPO Year
- FBRX N/A
- CUBA N/A
- Fundamental
- Price
- FBRX $7.35
- CUBA $2.64
- Analyst Decision
- FBRX Strong Buy
- CUBA
- Analyst Count
- FBRX 4
- CUBA 0
- Target Price
- FBRX $76.58
- CUBA N/A
- AVG Volume (30 Days)
- FBRX 54.6K
- CUBA 93.9K
- Earning Date
- FBRX 05-12-2025
- CUBA 01-01-0001
- Dividend Yield
- FBRX N/A
- CUBA 20.83%
- EPS Growth
- FBRX N/A
- CUBA N/A
- EPS
- FBRX N/A
- CUBA N/A
- Revenue
- FBRX N/A
- CUBA N/A
- Revenue This Year
- FBRX N/A
- CUBA N/A
- Revenue Next Year
- FBRX N/A
- CUBA N/A
- P/E Ratio
- FBRX N/A
- CUBA N/A
- Revenue Growth
- FBRX N/A
- CUBA N/A
- 52 Week Low
- FBRX $4.11
- CUBA $2.25
- 52 Week High
- FBRX $28.68
- CUBA $4.14
- Technical
- Relative Strength Index (RSI)
- FBRX 44.84
- CUBA 55.17
- Support Level
- FBRX $7.10
- CUBA $2.56
- Resistance Level
- FBRX $9.04
- CUBA $2.70
- Average True Range (ATR)
- FBRX 1.32
- CUBA 0.06
- MACD
- FBRX 0.34
- CUBA -0.01
- Stochastic Oscillator
- FBRX 50.62
- CUBA 47.59
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About CUBA Herzfeld Caribbean Basin Fund Inc. (The)
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.